1) Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part ii: The aging heart in health: Links to heart disease. Circulation. 2003; 107: 346-54
|
|
|
2) Kenyon C. The plasticity of aging: Insights from long-lived mutants. Cell. 2005; 120: 449-60
|
|
|
3) Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science. 2003; 299: 572-4
|
|
|
4) Taguchi A, Wartschow LM, White MF. Brain irs2 signaling coordinates life span and nutrient homeostasis. Science. 2007; 317: 369-72
|
|
|
5) Wessells RJ, Fitzgerald E, Cypser JR, et al. Insulin regulation of heart function in aging fruit flies. Nat Genet. 2004; 36: 1275-81
|
|
|
6) Inuzuka Y, Okuda J, Kawashima T, et al. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation. 2009; 120: 1695-703
|
|
|
7) Terrell D, Robbins J. Protein conformation-based disease: Getting to the heart of the matter. Annu Rev Physiol. 2010; 72: 15-7
|
|
|
8) Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007; 13: 619-24
|
|
|
9) Gottlieb RA, Mentzer RM. Autophagy during cardiac stress: Joys and frustrations of autophagy. Annu Rev Physiol. 2010; 72: 45-59
|
|
|
10) Matsuda N, Sato S, Shiba K, et al. Pink1 stabilized by mitochondrial depolarization recruits parkin to damaged mitochondria and activates latent parkin for mitophagy. J Cell Biol. 2010; 189: 211-21
|
|
|
11) Ban K, Cooper AJ, Samuel S, et al. Phosphatidyl-inositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning. Circ Res. 2008; 103: 643-53
|
|
|
12) McMullen JR, Shioi T, Zhang L, et al. Phospho-inositide 3-kinase (p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A. 2003; 100: 12355-60
|
|
|
13) McMullen JR, Shioi T, Huang WY, et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phospho-inositide 3-kinase (p110alpha) pathway. J Biol Chem. 2004; 279: 4782-93
|
|
|
14) Neubauer S. The failing heart--an engine out of fuel. N Engl J Med. 2007; 356: 1140-51
|
|
|
15) Kato T, Niizuma S, Inuzuka Y, et al. Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure. Circ Heart Fail. 2010; 3: 420-30
|
|
|
16) Bolanos JP, Almeida A, Moncada S. Glycolysis: A bioenergetic or a survival pathway? Trends Biochem Sci. 2010; 35: 145-9
|
|
|
17) Doehner W, Rauchhaus M, Ponikowski P, et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol. 2005; 46: 1019-26
|
|
|
18) Ishii N, Nakahigashi K, Baba T, et al. Multiple high-throughput analyses monitor the response of E. coli to perturbations. Science. 2007; 316: 593-7
|
|
|
19) Soukoulis V, Dihu JB, Sole M, et al. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol. 2009; 54: 1660-73
|
|
|